Triumphant return of the J2R 2023 at Tours: A whirlwind of scientific exchanges and emotion
Rev Mal Respir. 2024 Mar;41(3):180-182. doi: 10.1016/j.rmr.2024.03.002.NO ABSTRACTPMID:38514243 | DOI:10.1016/j.rmr.2024.03.002 (Source: Revue des Maladies Respiratoires)
Source: Revue des Maladies Respiratoires - March 21, 2024 Category: Respiratory Medicine Authors: I Annesi-Maesano P Bonniaud G Bouchaud L Boyer S Gazzeri P Gosset D Gras C Guibert C Guignabert B Mari S Matecki C Mor élot C Pilette C Planes L Plantier M Polette M Si-Tahar C Taill é I Vachier membres du groupe RESPIRenT Source Type: research
The role of the pulmonologist in the therapeutic strategy for stage I bronchopulmonary cancers?
Rev Mal Respir. 2024 Mar;41(3):172-174. doi: 10.1016/j.rmr.2024.03.001.NO ABSTRACTPMID:38514242 | DOI:10.1016/j.rmr.2024.03.001 (Source: Revue des Maladies Respiratoires)
Source: Revue des Maladies Respiratoires - March 21, 2024 Category: Respiratory Medicine Authors: V Gounant A Khalil G Zalcman Source Type: research
Triumphant return of the J2R 2023 at Tours: A whirlwind of scientific exchanges and emotion
Rev Mal Respir. 2024 Mar;41(3):180-182. doi: 10.1016/j.rmr.2024.03.002.NO ABSTRACTPMID:38514243 | DOI:10.1016/j.rmr.2024.03.002 (Source: Revue des Maladies Respiratoires)
Source: Revue des Maladies Respiratoires - March 21, 2024 Category: Respiratory Medicine Authors: I Annesi-Maesano P Bonniaud G Bouchaud L Boyer S Gazzeri P Gosset D Gras C Guibert C Guignabert B Mari S Matecki C Mor élot C Pilette C Planes L Plantier M Polette M Si-Tahar C Taill é I Vachier membres du groupe RESPIRenT Source Type: research
The role of the pulmonologist in the therapeutic strategy for stage I bronchopulmonary cancers?
Rev Mal Respir. 2024 Mar;41(3):172-174. doi: 10.1016/j.rmr.2024.03.001.NO ABSTRACTPMID:38514242 | DOI:10.1016/j.rmr.2024.03.001 (Source: Revue des Maladies Respiratoires)
Source: Revue des Maladies Respiratoires - March 21, 2024 Category: Respiratory Medicine Authors: V Gounant A Khalil G Zalcman Source Type: research
Triumphant return of the J2R 2023 at Tours: A whirlwind of scientific exchanges and emotion
Rev Mal Respir. 2024 Mar;41(3):180-182. doi: 10.1016/j.rmr.2024.03.002.NO ABSTRACTPMID:38514243 | DOI:10.1016/j.rmr.2024.03.002 (Source: Revue des Maladies Respiratoires)
Source: Revue des Maladies Respiratoires - March 21, 2024 Category: Respiratory Medicine Authors: I Annesi-Maesano P Bonniaud G Bouchaud L Boyer S Gazzeri P Gosset D Gras C Guibert C Guignabert B Mari S Matecki C Mor élot C Pilette C Planes L Plantier M Polette M Si-Tahar C Taill é I Vachier membres du groupe RESPIRenT Source Type: research
Idiopathic pulmonary fibrosis: Desperately seeking a model
Rev Mal Respir. 2024 Mar 12:S0761-8425(24)00139-6. doi: 10.1016/j.rmr.2024.02.009. Online ahead of print.ABSTRACTIdiopathic pulmonary fibrosis (IPF) is a chronic, progressive and fatal lung disease of which the origin and development mechanisms remain unknown. The few available pharmacological treatments can only slow the progression of the disease. The development of curative treatments is hampered by the absence of experimental models that can mimic the specific pathophysiological mechanisms of IPF. The aim of this mini-review is to provide an overview of the most commonly used experimental animal models in the study of ...
Source: Revue des Maladies Respiratoires - March 13, 2024 Category: Respiratory Medicine Authors: N Hennion C Chenivesse S Humez F Gottrand J-L Desseyn V Gouyer Source Type: research
Modifications of distal pathways in COPD, in light of recent technological advances in imaging and transcriptomics
The objective of this review is to provide an updated overall vision of knowledge on distal airways and how they are damaged in COPD.PMID:38480097 | DOI:10.1016/j.rmr.2024.02.008 (Source: Revue des Maladies Respiratoires)
Source: Revue des Maladies Respiratoires - March 13, 2024 Category: Respiratory Medicine Authors: K Raasch I Dupin Source Type: research
Idiopathic pulmonary fibrosis: Desperately seeking a model
Rev Mal Respir. 2024 Mar 12:S0761-8425(24)00139-6. doi: 10.1016/j.rmr.2024.02.009. Online ahead of print.ABSTRACTIdiopathic pulmonary fibrosis (IPF) is a chronic, progressive and fatal lung disease of which the origin and development mechanisms remain unknown. The few available pharmacological treatments can only slow the progression of the disease. The development of curative treatments is hampered by the absence of experimental models that can mimic the specific pathophysiological mechanisms of IPF. The aim of this mini-review is to provide an overview of the most commonly used experimental animal models in the study of ...
Source: Revue des Maladies Respiratoires - March 13, 2024 Category: Respiratory Medicine Authors: N Hennion C Chenivesse S Humez F Gottrand J-L Desseyn V Gouyer Source Type: research
Modifications of distal pathways in COPD, in light of recent technological advances in imaging and transcriptomics
The objective of this review is to provide an updated overall vision of knowledge on distal airways and how they are damaged in COPD.PMID:38480097 | DOI:10.1016/j.rmr.2024.02.008 (Source: Revue des Maladies Respiratoires)
Source: Revue des Maladies Respiratoires - March 13, 2024 Category: Respiratory Medicine Authors: K Raasch I Dupin Source Type: research
Idiopathic pulmonary fibrosis: Desperately seeking a model
Rev Mal Respir. 2024 Mar 12:S0761-8425(24)00139-6. doi: 10.1016/j.rmr.2024.02.009. Online ahead of print.ABSTRACTIdiopathic pulmonary fibrosis (IPF) is a chronic, progressive and fatal lung disease of which the origin and development mechanisms remain unknown. The few available pharmacological treatments can only slow the progression of the disease. The development of curative treatments is hampered by the absence of experimental models that can mimic the specific pathophysiological mechanisms of IPF. The aim of this mini-review is to provide an overview of the most commonly used experimental animal models in the study of ...
Source: Revue des Maladies Respiratoires - March 13, 2024 Category: Respiratory Medicine Authors: N Hennion C Chenivesse S Humez F Gottrand J-L Desseyn V Gouyer Source Type: research
Modifications of distal pathways in COPD, in light of recent technological advances in imaging and transcriptomics
The objective of this review is to provide an updated overall vision of knowledge on distal airways and how they are damaged in COPD.PMID:38480097 | DOI:10.1016/j.rmr.2024.02.008 (Source: Revue des Maladies Respiratoires)
Source: Revue des Maladies Respiratoires - March 13, 2024 Category: Respiratory Medicine Authors: K Raasch I Dupin Source Type: research
Idiopathic pulmonary fibrosis: Desperately seeking a model
Rev Mal Respir. 2024 Mar 12:S0761-8425(24)00139-6. doi: 10.1016/j.rmr.2024.02.009. Online ahead of print.ABSTRACTIdiopathic pulmonary fibrosis (IPF) is a chronic, progressive and fatal lung disease of which the origin and development mechanisms remain unknown. The few available pharmacological treatments can only slow the progression of the disease. The development of curative treatments is hampered by the absence of experimental models that can mimic the specific pathophysiological mechanisms of IPF. The aim of this mini-review is to provide an overview of the most commonly used experimental animal models in the study of ...
Source: Revue des Maladies Respiratoires - March 13, 2024 Category: Respiratory Medicine Authors: N Hennion C Chenivesse S Humez F Gottrand J-L Desseyn V Gouyer Source Type: research
Modifications of distal pathways in COPD, in light of recent technological advances in imaging and transcriptomics
The objective of this review is to provide an updated overall vision of knowledge on distal airways and how they are damaged in COPD.PMID:38480097 | DOI:10.1016/j.rmr.2024.02.008 (Source: Revue des Maladies Respiratoires)
Source: Revue des Maladies Respiratoires - March 13, 2024 Category: Respiratory Medicine Authors: K Raasch I Dupin Source Type: research
Idiopathic pulmonary fibrosis: Desperately seeking a model
Rev Mal Respir. 2024 Mar 12:S0761-8425(24)00139-6. doi: 10.1016/j.rmr.2024.02.009. Online ahead of print.ABSTRACTIdiopathic pulmonary fibrosis (IPF) is a chronic, progressive and fatal lung disease of which the origin and development mechanisms remain unknown. The few available pharmacological treatments can only slow the progression of the disease. The development of curative treatments is hampered by the absence of experimental models that can mimic the specific pathophysiological mechanisms of IPF. The aim of this mini-review is to provide an overview of the most commonly used experimental animal models in the study of ...
Source: Revue des Maladies Respiratoires - March 13, 2024 Category: Respiratory Medicine Authors: N Hennion C Chenivesse S Humez F Gottrand J-L Desseyn V Gouyer Source Type: research
Modifications of distal pathways in COPD, in light of recent technological advances in imaging and transcriptomics
The objective of this review is to provide an updated overall vision of knowledge on distal airways and how they are damaged in COPD.PMID:38480097 | DOI:10.1016/j.rmr.2024.02.008 (Source: Revue des Maladies Respiratoires)
Source: Revue des Maladies Respiratoires - March 13, 2024 Category: Respiratory Medicine Authors: K Raasch I Dupin Source Type: research
